PACBVSTXG• 28 Days (Normalized)
PACB vs TXG (Pacific Biosciences of California Inc. vs 10x Genomics Inc.)
Showing Closing Date Range from Sep 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
PACB Performance $2.72
+110.85%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
TXG Performance $76.1
+13.09%
10x Genomics Inc.
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
+97.76 pts
PACB outperforming by 97.76 percentage points
PACBTXG
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
PACB TXG
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | PACB Price | PACB Gain (%) | TXG Price | TXG Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $2.72 | +110.85% | $76.10 | +13.09% | +97.76% |
| Oct 06, 2026 | $2.70 | +109.30% | $80.66 | +19.87% | +89.43% |
| Oct 05, 2026 | $2.87 | +122.48% | $97.74 | +45.25% | +77.23% |
| Oct 02, 2026 | $2.54 | +96.90% | $93.50 | +38.95% | +57.95% |
| Oct 01, 2026 | $2.51 | +94.57% | $88.76 | +31.91% | +62.66% |
| Sep 30, 2026 | $2.37 | +83.72% | $90.36 | +34.28% | +49.44% |
| Sep 29, 2026 | $1.83 | +41.86% | $90.04 | +33.81% | +8.05% |
| Sep 28, 2026 | $1.71 | +32.56% | $88.50 | +31.52% | +1.04% |
| Sep 25, 2026 | $- | $85.71 | +27.37% | - | |
| Sep 24, 2026 | $1.46 | +12.79% | $84.11 | +25.00% | -12.21% |
| Sep 23, 2026 | $1.41 | +9.30% | $75.62 | +12.38% | -3.08% |
| Sep 22, 2026 | $- | $80.70 | +19.93% | - | |
| Sep 21, 2026 | $1.36 | +5.43% | $79.10 | +17.55% | -12.12% |
| Sep 18, 2026 | $1.37 | +6.20% | $76.60 | +13.84% | -7.64% |
| Sep 17, 2026 | $1.38 | +6.98% | $76.97 | +14.39% | -7.41% |
Page 1 of 2